Prospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7795-7805
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7795
Table 3 Univariate and multivariate analyses of survival outcomes
VariableUnivariate analysis

Multivariate analysis

HR (95%CI)
P value
HR (95%CI)
P value
Overall survival
Group
LG1 (reference)1 (reference)
OG1.28 (0.67-2.45)0.461.24 (0.64-2.40)0.52
Age
≤ 601 (reference)1 (reference)
> 601.35 (0.72-2.54)0.351.32 (0.69-2.51)0.40
Sex
Male1 (reference)1 (reference)
Female0.86 (0.45-1.64)0.650.84 (0.43-1.61)0.59
BMI
≤ 251 (reference)1 (reference)
> 251.12 (0.58-2.16)0.741.09 (0.56-2.13)0.79
Tumor location
Upper third1 (reference)1 (reference)
Middle third0.97 (0.47-2.01)0.940.95 (0.45-1.98)0.89
Lower third0.92 (0.44-1.91)0.820.89 (0.42-1.86)0.75
Tumor size
≤ 5 cm1 (reference)1 (reference)
> 5 cm1.41 (0.75-2.65)0.281.38 (0.72-2.62)0.32
Pathological stage1
II1 (reference)1 (reference)
III2.15 (1.12-4.13)0.022.12 (1.09-4.10)0.03
Pathological response2
Complete1 (reference)1 (reference)
Partial1.22 (0.38-3.94)0.741.18 (0.36-3.86)0.79
Stable1.45 (0.45-4.66)0.541.41 (0.43-4.59)0.57
Progressive2.67 (0.81-8.80)0.112.61 (0.78-8.68)0.12
Disease-free survival
Group
LG1 (reference)1 (reference)
OG1.19 (0.64-2.21)0.581.16 (0.62-2.17)0.64
Age
≤ 601 (reference)1 (reference)
> 601.25 (0.68-2.30)0.471.23 (0.66-2.27)0.51
Sex
Male1 (reference)1 (reference)
Female0.91 (0.49-1.70)0.770.89 (0.47-1.66)0.71
BMI
≤ 251 (reference)1 (reference)
> 251.08 (0.57-2.05)0.811.05 (0.54-2.01)0.88
Tumor location
Upper third1 (reference)1 (reference)
Middle third0.99 (0.49-2.02)0.980.97 (0.47-1.99)0.93
Lower third0.94 (0.46-1.93)0.870.91 (0.44-1.88)0.80
Tumor size
≤ 5 cm1 (reference)1 (reference)
> 5 cm1.32 (0.72-2.42)0.371.29 (0.69-2.38)0.42
Pathological stage
II1 (reference)1 (reference)
III2.03 (1.08-3.81)0.032.01 (1.06-3.78)0.03
Pathological response
Complete1 (reference)1 (reference)
Partial1.18 (0.38-3.67)0.781.15 (0.36-3.59)0.82
Stable1.36 (0.43-4.30)0.601.32 (0.41-4.23)0.64
Progressive2.49 (0.77-8.070.132.43 (0.74-7.97) 0.14